1. Home
  2. GFF vs ABCL Comparison

GFF vs ABCL Comparison

Compare GFF & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Griffon Corporation

GFF

Griffon Corporation

N/A

Current Price

$101.46

Market Cap

4.2B

Sector

Industrials

ML Signal

N/A

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

N/A

Current Price

$11.86

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GFF
ABCL
Founded
1959
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.1B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
GFF
ABCL
Price
$101.46
$11.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
13
Target Price
★ $126.86
$17.17
AVG Volume (30 Days)
307.2K
★ 3.7M
Earning Date
11-18-2026
11-09-2026
Dividend Yield
★ 0.86%
N/A
EPS Growth
N/A
★ 10.91
EPS
★ 2.97
N/A
Revenue
★ $2,519,926,000.00
$75,128,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.13
$7.12
P/E Ratio
$36.20
★ N/A
Revenue Growth
N/A
★ 160.56
52 Week Low
$65.01
$2.75
52 Week High
$108.57
$14.98

Technical Indicators

Market Signals
Indicator
GFF
ABCL
Relative Strength Index (RSI) 57.52 47.54
Support Level $88.25 $11.78
Resistance Level $108.57 $13.21
Average True Range (ATR) 3.21 0.93
MACD 0.67 -0.11
Stochastic Oscillator 56.76 33.87

Price Performance

Historical Comparison
GFF
ABCL

About GFF Griffon Corporation

Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals. Its operating segments include Consumer and Professional Products: is a provider of branded consumer and professional tools; residential, industrial and commercial fans; home storage and organization products; and Home and Building Products conducts its operations through Clopay Corporation (Clopay). Clopay is the manufacturer and marketer of garage doors and rolling steel doors in North America. The company generates a majority of its revenue from the Home and Building Products segment. Operates in USA, Europe, Canada, Australia, and Others.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: